EPO and hepatocellular carcinoma: In 1992, Semenza et al. first reported the nuclear transcription factor induced by hypoxia in Hep3B HCC cell line, which was termed as HIF-1α and acted as an enhancer of erythropoietin (EPO) gene [130].